|
Jane E. Henney, M.D.
1/17/1999 - 1/19/2001*
Dr. Henney began her tenure as Commissioner of the Food and Drug
Administration (FDA) in November of 1998. Prior to that, she served
as the first Vice President of the University of New Mexico Health
Sciences from 1994 to 1998. Before joining the University, Dr. Henney
served as the Deputy Commissioner for Operations at FDA from 1992
to 1994. Dr. Henney's other past academic administrative positions
have included Vice Chancellor for Health Programs and Policy at
the University of Kansas, and Acting Director of the University
of Kansas Mid America Cancer Center from 1985 to 1992. She also
served as Interim Dean of the School of Medicine at the University
of Kansas from 1987 to 1989. From 1976 to 1985, Dr. Henney held
various positions at the National Cancer Institute (NCI) of the
National Institutes of Health. From 1980-1985, Dr. Henney was Deputy
Director of the NCI.
In addition to being an active member of many professional societies,
Dr. Henney has been the President of the United States Pharmacopeial
Convention, a member of the Advisory Committee to the Director for
the National Institutes of Health, a member of the National Advisory
Research Resources Council, and a member of the American Cancer
Society National Board of Directors. She has served as a member
of the Board of Directors of the Lovelace Respiratory Institute,
the Kansas Health Foundation, and the Kansas State University Cancer
Center. Dr. Henney also has served on an Advisory Committee for
The Commonwealth Fund and as a consultant to the W.K. Kellogg Foundation.
She currently serves as a member of the Board of Trustees at Manchester
College.
Dr. Henney is a graduate of Indiana University School of Medicine
and Manchester College. She completed her medical internship at
St. Vincent's Hospital, and her residency at Georgia Baptist Hospital.
Dr. Henney was a Fellow in Medical Oncology at M.D. Anderson Hospital
and Tumor Institute, and completed graduate medical work at the
Cancer Therapy Evaluation Program at NCI. She has also completed
management training at the John F. Kennedy School of Government
at Harvard University.
In addition to other distinguished honors, Dr. Henney was recently
given an Honorary Fellowship from the American College of Healthcare
Executives. She also received the Indiana University Medical School
Distinguished Alumni Award in 1998, the Manchester College Alumni
Award in 1996, and was a member of the Leadership New Mexico Inaugural
Class in 1996-1997. Dr. Henney received the Public Health Service
Commendation Medal in 1979 and 1981, and the Commissioner's Special
Citation in 1994. Most recently, Dr. Henney has received the Jacobs
Institute's Excellence in Women's Health Award and the Public Health
Leadership Award from the National Organization for Rare Disorders.
* The post of commissioner was vacant from
Jan. 19, 2001 until November 2002. Bernard A. Schwetz served as
acting principal deputy commissioner from Jan. 21, 2001 until Feb.
24, 2002. At that time, Lester M. Crawford Jr. was appointed deputy
commissioner and he headed the agency until Mark McClellan was appointed
commissioner in November 2002. With Dr. McClellan's departure
in March 2004, Dr. Crawford was again named to lead FDA, this time
as acting commissioner.
Top of page
|
 |
